Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Fast Biomedical logo — Quantifying the previously unmeasurable with advanced medica...

Fast Biomedical

Quantifying the previously unmeasurable with advanced medical technology.

Founded 2006 Series A Total: $15.08M Biotechnology, Health Care +1

General Information

Company Name Fast Biomedical
Founded Year 2006
Industries Biotechnology, Health Care, Information Technology
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Fast Biomedical. To contact Fast Biomedical, visit fastbiomedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Fast Biomedical compare?

A PDF of Fast Biomedical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Fast Biomedical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Fast Biomedical

Fast Biomedical is a pioneering medical technology startup with a compelling slogan, "Quantifying the previously unmeasurable with advanced medical technology." Since its foundation in 2006, the Indiana-based company has been dedicated to contributing to the advancement of the biotechnology, healthcare, and information technology industries. Fast Biomedical's vision revolves around the development and commercialization of a patented technology capable of accurately quantifying clinically relevant parameters that were previously difficult or impossible to measure. The company received a significant boost with its $5.00M Series A investment, which took place on 05 May 2017. The funding came from F&M INVESTMENT OFFICE, signifying the confidence and trust that notable investors have in Fast Biomedical's potential. This injection of capital not only showcases the commitment of investors to the startup but also underlines the belief in the value and innovation Fast Biomedical brings to the medical technology landscape. Overall, Fast Biomedical's innovative technology, combined with its successful funding efforts, positions the company as a promising player in the healthcare and biotechnology sectors, with the potential to make meaningful contributions to shaping the future of medical technology.

Business keywords: clinical stage, biomedical, technology development, commercialization, quantification, innovation, measurement, clinical parameters, patented technology, Indiana-based, investor analysis

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $3.00M 1
National Institutes of Health
05 May 2017
Series A $5.00M 1
F&M INVESTMENT OFFICE
05 May 2017
Debt Financing $875.00K -
13 Aug 2015
Venture Round $930.00K 1
Elevate Ventures
Elevate Ventures
01 May 2013
Venture Round $2.40M -
08 Mar 2013
Venture Round $2.88M -
17 May 2011

Fast Biomedical Alternatives & Competitors

View All Alternatives
Fast Biomedical vs
UNeMed Corporation
UNeMed Corporation United States

Tech transfer & commercialization for the University of Nebraska Medical Center and the University o...

20 employees
Biotechnology, Health Care
Fast Biomedical vs
QRxPharma
QRxPharma

Pioneering pain management with innovative products and advanced abuse prevention technologies

Post-IPO Equity
Biopharma, Biotechnology
Fast Biomedical vs
Cloudbreak Therapeutics
Cloudbreak Therapeutics

Leading the future of eye care with efficient drug repurposing and fast-tracked clinical advancement...

Series C
11-50 employees
Biotechnology, Health Care
View all alternatives

FAQ About Fast Biomedical

Quantifying the previously unmeasurable with advanced medical technology.
Fast Biomedical was founded in 2006.
Fast Biomedical operates in Biotechnology, Health Care and Information Technology. Its work centres on clinical stage, biomedical, technology development and commercialization.
Fast Biomedical has completed 6 funding rounds, raising a total of $15.08M. The latest funding stage is Series A.
Top alternatives and competitors to Fast Biomedical include UNeMed Corporation, QRxPharma, Cloudbreak Therapeutics, VectivBio, ChitogenX. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Fast Biomedical and UNeMed Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Fast Biomedical, https://bouncewatch.com/company/fast-biomedical, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes